137 related articles for article (PubMed ID: 9487003)
21. [Antimycotic therapy of Tinea unguium and other onychomycoses].
Stock I
Med Monatsschr Pharm; 2009 Aug; 32(8):289-98; quiz 299-300. PubMed ID: 19777736
[TBL] [Abstract][Full Text] [Related]
22. Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study Group.
Alomar A; Videla S; Delgadillo J; Gich I; Izquierdo I; Forn J
Dermatology; 1995; 190(4):295-300. PubMed ID: 7655109
[TBL] [Abstract][Full Text] [Related]
23. [Antifungal Activity of Luliconazole Nail Solution on in vitro and in vivo Onychomycosis Model].
Shimamura T; Hasegawa N; Kubota N
Med Mycol J; 2016; 57(1):J13-8. PubMed ID: 26936347
[TBL] [Abstract][Full Text] [Related]
24. Case of Fusarium paronychia successfully treated with occlusive dressing of antifungal cream.
Ikeda I; Ohno T; Ohno H; Miyazaki Y; Nishimoto K; Fukushima S; Makino T; Ihn H
J Dermatol; 2014 Apr; 41(4):340-2. PubMed ID: 24533442
[TBL] [Abstract][Full Text] [Related]
25. [Onychomycoses and their successful therapy].
Nolting S
Wien Med Wochenschr; 1989 Aug; 139(15-16):354-5. PubMed ID: 2531958
[TBL] [Abstract][Full Text] [Related]
26. [Treatment onychomycoses--bifonazole nail set in comparison with urea with ciclopiroxolamine formulation].
Rüping KW; Haas PJ
Z Arztl Fortbild (Jena); 1993 Apr; 87(5):425-9. PubMed ID: 8322470
[No Abstract] [Full Text] [Related]
27. Efficacy and safety of bifonazole urea in the two-phase treatment of onychomycosis.
Bonifaz A; Guzmán A; Garcia C; Sosa J; Saúl A
Int J Dermatol; 1995 Jul; 34(7):500-3. PubMed ID: 7591419
[No Abstract] [Full Text] [Related]
28. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
Watanabe S; Kishida H; Okubo A
J Dermatol; 2017 Jul; 44(7):753-759. PubMed ID: 28332720
[TBL] [Abstract][Full Text] [Related]
29. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
Gupta AK; Fleckman P; Baran R
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
[TBL] [Abstract][Full Text] [Related]
30. A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen® dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis.
Parekh M; Ramaiah G; Pashilkar P; Ramanujam R; Johnston P; Ilag LL
BMC Complement Altern Med; 2017 Sep; 17(1):464. PubMed ID: 28923039
[TBL] [Abstract][Full Text] [Related]
31. Combination therapy of once-weekly fluconazole (100, 150, or 300 mg) with topical application of ketoconazole cream in the treatment of onychomycosis.
Chen X; Hiruma M; Shiraki Y; Ogawa H
Jpn J Infect Dis; 2004 Dec; 57(6):260-3. PubMed ID: 15623951
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of ciclopiroxolamine 1% cream in onychomycosis and tinea pedis.
Wu YC; Chuan MT; Lü YC
Mycoses; 1991; 34(1-2):93-5. PubMed ID: 1833642
[TBL] [Abstract][Full Text] [Related]
34. Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure.
Shemer A; Gupta AK; Kamshov A; Babaev M; Farhi R; Daniel CR; Foley KA
Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28856784
[TBL] [Abstract][Full Text] [Related]
35. Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals.
Tosti A; Piraccini BM; Stinchi C; Lorenzi S
Br J Dermatol; 1996 Nov; 135(5):799-802. PubMed ID: 8977686
[TBL] [Abstract][Full Text] [Related]
36. Efficacious treatment of non-dermatophyte mould onychomycosis with topical amphotericin B.
Lurati M; Baudraz-Rosselet F; Vernez M; Spring P; Bontems O; Fratti M; Monod M
Dermatology; 2011; 223(4):289-92. PubMed ID: 22236569
[TBL] [Abstract][Full Text] [Related]
37. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.
Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S
J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989
[TBL] [Abstract][Full Text] [Related]
38. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of fractional carbon dioxide (CO
Shi J; Li J; Huang H; Permatasari F; Liu J; Xu Y; Wu D; Zhou BR; Luo D
J Cosmet Laser Ther; 2017 Oct; 19(6):353-359. PubMed ID: 28557542
[TBL] [Abstract][Full Text] [Related]
40. [Usefulness of bifonazole for treatment of tinea pedis in the 20th year after approval].
Mitsui H; Kanda N; Ohnishi T; Nakai K; Suzuki T; Watanabe S
Jpn J Antibiot; 2009 Apr; 62(2):79-89. PubMed ID: 19673350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
